WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin : vimarsana.com

The clarifications are sought to conduct a final 'risk-benefit assessment' for Emergency Use Listing of the vaccine

Related Keywords

India , Bharat , Margaret Harris , Johnson Janssen , Pfizer , Bio Serum Institute Of India , Astrazeneca , Technical Advisory Group , Technical Advisory Group For Emergency Use Listing , Oxford University Covishield , World Health Organisation , Bharat Biotech , Emergency Use Listing , Oxford University , Serum Institute , Covaxin , Covaxin Who Approval , Bharat Biotech Covaxin Approval , Harat Biotech Covaxin Who Approval , Who Covaxin Approval , Ho Covaxin Bharat Biotech Approval , Ho Covaxin Approval Bharat Biotech ,